Active pharmaceutical ingredients of ARV drugs

The AIDS Medicines and Diagnostics Service (AMDS) publishes results of periodic surveys on Active Pharmaceutical Ingredients (APIs) of antiretroviral (ARV) drugs, based on information provided by manufacturers on their API products, production capacity, prices and regulatory statuses of these products. Majority of companies are from India and China, while many of them are producers with original patents of the APIs.


All data and information available in the Sources, Quality and Prices of Active Pharmaceutical Ingredients (API) for antiretroviral medicines has been provided by the manufacturers and has not been verified. WHO makes no representations or warranties, either expressed or implied, as to their accuracy, completeness or fitness for a particular purpose. Neither does WHO accept any responsibility or liability with regard to the reliance on, or use of, such data and information.

WHO has made every effort to ensure the accuracy of the information presented, but the readers should realize that manufacturing and production capacity are a highly dynamic area, and that data can therefore never be complete. The data and information contained herein are being provided as is. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO, in preference to others of a similar nature that are not mentioned. However, some products on this list have been pre-qualified for procurement by the WHO pre-qualification pilot project, and have been endorsed by the Organization. This is the only endorsement WHO gives to pharmaceutical products. The list of WHO pre-qualified API is available on the following web site: